Added Value of Advanced over Conventional Magnetic Resonance Imaging in Grading Gliomas and Other Primary Brain Tumors

Overview

Journal Cancer Imaging

Publisher Springer Nature

Specialties Oncology
Radiology

Date 2015 Jan 23

PMID 25608821

Citations 32

Authors

Juan A Guzman-De-Villoria

Jose M Mateos-Perez

Pilar Fernandez-Garcia

Enrique Castro

Manuel Desco

Affiliations

Soon will be listed here.

Abstract

Background: Although conventional MR imaging (MRI) is the most widely used non-invasive technique for brain tumor grading, its accuracy has been reported to be relatively low. Advanced MR techniques, such as perfusion-weighted imaging (PWI), diffusion-weighted imaging (DWI), and magnetic resonance spectroscopy (MRS), could predict neoplastic histology, but their added value over conventional MRI is still open to debate.

Methods: We prospectively analyzed 129 patients diagnosed with primary brain tumors (118 gliomas) classified as low-grade in 30 cases and high-grade in 99 cases.

Results: Significant differences were obtained in high-grade tumors for conventional MRI variables (necrosis, enhancement, edema, hemorrhage, and neovascularization); high relative cerebral blood volume values (rCBV), low relative apparent diffusion coefficients (rADC), high ratio of N-acetyl-aspartate/creatine at short echo time (TE) and high choline/creatine at long TE. Among conventional MRI variables, the presence of enhancement and necrosis were demonstrated to be the best predictors of high grade in primary brain tumors (sensitivity 95.9%; specificity 70%). The best results in primary brain tumors were obtained for enhancement, necrosis, and rADC (sensitivity 98.9%; specificity 75.9%). Necrosis and enhancement were the only predictors of high grade in gliomas (sensitivity 97.6%; specificity 76%) when all the magnetic resonance variables were combined.

Conclusions: MRI is highly accurate in the assessment of tumor grade. The combination of conventional MRI features with advanced MR variables showed only improved tumor grading by adding rADC to conventional MRI variables in primary brain tumors.

Citing Articles

Applying chemical shift images (in-phase/opposed phased) for differentiating low-grade from high-grade glioma and comparison with magnetic resonance spectroscopy.

Abbasi B, Ghamari Khameneh A, Zareh Soltaniye H, Darban Hosseini Amirkhiz G, Karimi E, Akhavan R Radiologie (Heidelb). 2024; 64(Suppl 1):116-122.

PMID: 38977491 DOI: 10.1007/s00117-024-01339-4.

Predicting glioblastoma recurrence using multiparametric MR imaging of non-enhancing peritumoral regions at baseline.

Xing Z, Wang C, Yang W, She D, Yang X, Cao D Heliyon. 2024; 10(9):e30411.

PMID: 38711642 PMC: 11070862. DOI: 10.1016/j.heliyon.2024.e30411.

A review on potential heterocycles for the treatment of glioblastoma targeting receptor tyrosine kinases.

Bhusare N, Kumar M Oncol Res. 2024; 32(5):849-875.

PMID: 38686058 PMC: 11055995. DOI: 10.32604/or.2024.047042.

A deep learning framework integrating MRI image preprocessing methods for brain tumor segmentation and classification.

Dang K, Vo T, Ngo L, Ha H IBRO Neurosci Rep. 2023; 13:523-532.

PMID: 36590099 PMC: 9795279. DOI: 10.1016/j.ibneur.2022.10.014.

Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics.

Balana C, Castaner S, Carrato C, Moran T, Lopez-Paradis A, Domenech M Front Neurol. 2022; 13:865171.

PMID: 35693015 PMC: 9177999. DOI: 10.3389/fneur.2022.865171.

References

Caulo M, Panara V, Tortora D, Mattei P, Briganti C, Pravata E . Data-driven grading of brain gliomas: a multiparametric MR imaging study. Radiology. 2014; 272(2):494-503. DOI: 10.1148/radiol.14132040. View

Molina V, Sanchez J, Sanz J, Reig S, Benito C, Leal I . Dorsolateral prefrontal N-acetyl-aspartate concentration in male patients with chronic schizophrenia and with chronic bipolar disorder. Eur Psychiatry. 2007; 22(8):505-12. DOI: 10.1016/j.eurpsy.2007.07.006. View

Yoon J, Kim J, Kang W, Sohn C, Choi S, Yun T . Grading of cerebral glioma with multiparametric MR imaging and 18F-FDG-PET: concordance and accuracy. Eur Radiol. 2013; 24(2):380-9. DOI: 10.1007/s00330-013-3019-3. View

Watanabe M, Tanaka R, Takeda N . Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology. 1992; 34(6):463-9. DOI: 10.1007/BF00598951. View

Lee E, Lee S, Agid R, Bae J, Keller A, terBrugge K . Preoperative grading of presumptive low-grade astrocytomas on MR imaging: diagnostic value of minimum apparent diffusion coefficient. AJNR Am J Neuroradiol. 2008; 29(10):1872-7. PMC: 8118927. DOI: 10.3174/ajnr.A1254. View

Svolos P, Kousi E, Kapsalaki E, Theodorou K, Fezoulidis I, Kappas C . The role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumors: a review and future perspectives. Cancer Imaging. 2015; 14:20. PMC: 4331825. DOI: 10.1186/1470-7330-14-20. View

Arvinda H, Kesavadas C, Sarma P, Thomas B, Radhakrishnan V, Gupta A . Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging. J Neurooncol. 2009; 94(1):87-96. DOI: 10.1007/s11060-009-9807-6. View

Opstad K, Murphy M, Wilkins P, Bell B, Griffiths J, Howe F . Differentiation of metastases from high-grade gliomas using short echo time 1H spectroscopy. J Magn Reson Imaging. 2004; 20(2):187-92. DOI: 10.1002/jmri.20093. View

Law M, Young R, Babb J, Pollack E, Johnson G . Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol. 2007; 28(4):761-6. PMC: 7977348. View

10.

Xu M, See S, Ng W, Arul E, Back M, Yeo T . Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery. 2005; 56(5):919-26. View

11.

Meyerand M, Pipas J, Mamourian A, Tosteson T, Dunn J . Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy. AJNR Am J Neuroradiol. 1999; 20(1):117-23. View

12.

Fayed N, Davila J, Medrano J, Olmos S . Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Eur J Radiol. 2008; 67(3):427-33. DOI: 10.1016/j.ejrad.2008.02.039. View

13.

Kaminogo M, Ishimaru H, Morikawa M, Ochi M, Ushijima R, Tani M . Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain. Neuroradiology. 2001; 43(5):353-63. DOI: 10.1007/s002340000473. View

14.

Leclerc X, Huisman T, Sorensen A . The potential of proton magnetic resonance spectroscopy ((1)H-MRS) in the diagnosis and management of patients with brain tumors. Curr Opin Oncol. 2002; 14(3):292-8. DOI: 10.1097/00001622-200205000-00007. View

15.

Paulson E, Schmainda K . Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology. 2008; 249(2):601-13. PMC: 2657863. DOI: 10.1148/radiol.2492071659. View

16.

Galanaud D, Nicoli F, Chinot O, Confort-Gouny S, Figarella-Branger D, Roche P . Noninvasive diagnostic assessment of brain tumors using combined in vivo MR imaging and spectroscopy. Magn Reson Med. 2006; 55(6):1236-45. DOI: 10.1002/mrm.20886. View

17.

Jackson R, Fuller G, Abi-Said D, Lang F, Gokaslan Z, Shi W . Limitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol. 2001; 3(3):193-200. PMC: 1920616. DOI: 10.1093/neuonc/3.3.193. View

18.

Zonari P, Baraldi P, Crisi G . Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Neuroradiology. 2007; 49(10):795-803. DOI: 10.1007/s00234-007-0253-x. View

19.

Weber M, Zoubaa S, Schlieter M, Juttler E, Huttner H, Geletneky K . Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology. 2006; 66(12):1899-906. DOI: 10.1212/01.wnl.0000219767.49705.9c. View

20.

Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109. PMC: 1929165. DOI: 10.1007/s00401-007-0243-4. View